Incheon, South Korea

Min Soo Kim

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Min Soo Kim - Innovator in Protein Expression Technology.

Introduction

Min Soo Kim is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the area of protein expression. His innovative work has led to advancements that enhance the functionality and efficiency of target protein production.

Latest Patents

Min Soo Kim holds a patent for an "Expression cassette for production of high-expression and high-functionality target protein and use thereof." This invention relates to an expression cassette that includes a promoter, a polynucleotide coding for the target protein, an intron sequence, and a poly A sequence, along with an expression vector and a transformant. The technology allows for the simultaneous expression of both the intron sequence and the target protein through a single transduction, thereby promoting high expression levels and functionality of the target protein by regulating the expression of an endogenous gene. He has 1 patent to his name.

Career Highlights

Min Soo Kim is currently employed at Celltrion Inc., a leading biopharmaceutical company. His role at Celltrion has allowed him to apply his expertise in protein expression technology to real-world applications, contributing to the development of innovative therapeutic solutions.

Collaborations

Throughout his career, Min Soo Kim has collaborated with notable colleagues, including Man Su Kim and Jong Moon Cho. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Min Soo Kim's contributions to protein expression technology exemplify the impact of innovative thinking in biotechnology. His patent and work at Celltrion Inc. highlight his commitment to advancing the field and improving the functionality of target proteins.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…